Law360, New York (October 29, 2009) -- Pfizer Inc. is again trying to fend off a lawsuit by a group of California pharmacies and pharmacists claiming the drugmaker's $68 billion buyout of rival Wyeth will eliminate competition and stifle innovation in the U.S. prescription drug market.
In a motion to dismiss filed Wednesday in the U.S. District Court for the Northern District of California, Pfizer and its Wyeth unit — which Pfizer acquired on Oct. 15...
